ADENIKE ADELEKE: Open Payments
NPI 1235757014 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,170 in 48 payments from 15 companies in 2025. Trend: 2023 $490 · 2024 $653 · 2025 $1,170
Food & beverage: $1,170
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $212 |
| ABBVIE INC. | 12 | $163 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $142 |
| Neurocrine BioSciences, Inc. | 2 | $140 |
| BETA BIONICS, INC. | 5 | $110 |
| CeQur Corporation | 1 | $104 |
| Brainsway USA INC | 1 | $96 |
| Madrigal Pharmaceuticals | 2 | $68 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Corium, LLC | 3 | $22 |
Products named: REXULTI, VRAYLAR, CAPLYTA, INGREZZA, iLet Bionic Pancreas, CeQur Simplicity, Deep TMS System, REZDIFFRA.
Industry payments across TX — which companies pay providers there.
